11-102790368-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002421.4(MMP1):c.*44A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 1,185,778 control chromosomes in the GnomAD database, including 70,945 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 8955 hom., cov: 33)
Exomes 𝑓: 0.34 ( 61990 hom. )
Consequence
MMP1
NM_002421.4 3_prime_UTR
NM_002421.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.215
Publications
27 publications found
Genes affected
MMP1 (HGNC:7155): (matrix metallopeptidase 1) This gene encodes a member of the peptidase M10 family of matrix metalloproteinases (MMPs). Proteins in this family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature protease. This secreted protease breaks down the interstitial collagens, including types I, II, and III. The gene is part of a cluster of MMP genes on chromosome 11. Mutations in this gene are associated with chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-102790368-T-C is Benign according to our data. Variant chr11-102790368-T-C is described in ClinVar as Benign. ClinVar VariationId is 1245928.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MMP1 | NM_002421.4 | c.*44A>G | 3_prime_UTR_variant | Exon 10 of 10 | ENST00000315274.7 | NP_002412.1 | ||
| MMP1 | NM_001145938.2 | c.*44A>G | 3_prime_UTR_variant | Exon 10 of 10 | NP_001139410.1 | |||
| WTAPP1 | NR_038390.1 | n.390-2777T>C | intron_variant | Intron 1 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.336 AC: 51147AN: 152012Hom.: 8951 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
51147
AN:
152012
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.313 AC: 66843AN: 213750 AF XY: 0.317 show subpopulations
GnomAD2 exomes
AF:
AC:
66843
AN:
213750
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.341 AC: 352787AN: 1033648Hom.: 61990 Cov.: 13 AF XY: 0.341 AC XY: 180694AN XY: 529690 show subpopulations
GnomAD4 exome
AF:
AC:
352787
AN:
1033648
Hom.:
Cov.:
13
AF XY:
AC XY:
180694
AN XY:
529690
show subpopulations
African (AFR)
AF:
AC:
8794
AN:
24274
American (AMR)
AF:
AC:
8222
AN:
36614
Ashkenazi Jewish (ASJ)
AF:
AC:
8536
AN:
21830
East Asian (EAS)
AF:
AC:
4381
AN:
37452
South Asian (SAS)
AF:
AC:
22149
AN:
69726
European-Finnish (FIN)
AF:
AC:
16023
AN:
51818
Middle Eastern (MID)
AF:
AC:
1202
AN:
3830
European-Non Finnish (NFE)
AF:
AC:
268236
AN:
742350
Other (OTH)
AF:
AC:
15244
AN:
45754
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
11166
22333
33499
44666
55832
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7040
14080
21120
28160
35200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.336 AC: 51178AN: 152130Hom.: 8955 Cov.: 33 AF XY: 0.329 AC XY: 24456AN XY: 74388 show subpopulations
GnomAD4 genome
AF:
AC:
51178
AN:
152130
Hom.:
Cov.:
33
AF XY:
AC XY:
24456
AN XY:
74388
show subpopulations
African (AFR)
AF:
AC:
15022
AN:
41494
American (AMR)
AF:
AC:
3964
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1369
AN:
3468
East Asian (EAS)
AF:
AC:
438
AN:
5190
South Asian (SAS)
AF:
AC:
1540
AN:
4814
European-Finnish (FIN)
AF:
AC:
3051
AN:
10576
Middle Eastern (MID)
AF:
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24770
AN:
67990
Other (OTH)
AF:
AC:
680
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1712
3425
5137
6850
8562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
806
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.